With the development tenet of "protecting health and loving life" and the mission of "making technology healthy life", the company is fully committed to the development of in vitro diagnostic test reagents with unity of knowledge and action.

Through cutting-edge multi-omics and bioinformatics analysis, we explore new disease markers, develop intelligent diagnostic analysis software, and strive to overcome multiple technical bottlenecks in the in vitro diagnostic industry, such as fully automatic, high-throughput, and multi-index rapid joint detection, to create the core technology of "differential innovative joint detection diagnostic reagents + intelligent analysis software + interpretation instruments". The detection projects include early diagnosis and screening of Alzheimer's disease, rapid detection series of sepsis, etc.